Risk factors of contrast-induced nephropathy in patients with acute coronary syndrome
Author(s) -
Tomasz Rakowski,
Artur Dziewierz,
Michał Węgiel,
Zbigniew Siudak,
Wojciech Zasada,
Jacek Jąkała,
Dominika Dykla,
Jerzy Matysek,
Andrzej Surdacki,
Stanisław Bartuś,
Dariusz Dudek,
Roman Wojdyła
Publication year - 2022
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2022.0123
Subject(s) - medicine , contrast induced nephropathy , percutaneous coronary intervention , conventional pci , acute coronary syndrome , myocardial infarction , anemia , nephropathy , cardiology , creatinine , diabetes mellitus , endocrinology
Patients with acute coronary syndrome (ACS) are at high risk of contrast-induced nephropathy (CIN), which is associated with prolonged hospitalization, higher morbidity and mortality after angiographic procedures. The occurrence of CIN is regarded as a transient and reversible condition. However, the persistence of CIN until hospital discharge in patients with ACS has not been thoroughly analyzed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom